Financing Plan - The company has received approval from the China Securities Regulatory Commission to issue convertible bonds totaling no more than 375 million yuan, aimed at funding the construction and upgrade of smart eyewear stores, the establishment of a headquarters management center, digital platform upgrades, and supplementing working capital [2] Business and Technology Development - The company is strengthening its collaboration in the smart eyewear sector, having established strategic partnerships with leading manufacturers such as Meizu, Thunderbird Innovation, XREAL, and Xiaomi, and plans to launch AI audio glasses through a joint venture [3] - Analysts suggest that the sales growth of smart eyewear is expected to become a performance growth point, although R&D investment has decreased year-on-year in the first three quarters of 2025 while marketing expenses remain high [3] Performance and Operating Conditions - In the first three quarters of 2025, the company's revenue increased by 18.05% year-on-year to 1.08 billion yuan, and net profit attributable to shareholders grew by 5.21% to 87.83 million yuan, but the company has not yet released its full-year performance report for 2025 [4] - The company has committed to timely information disclosure in accordance with regulations, making the annual performance announcement noteworthy [4] Recent Events - On December 18, 2025, the company announced that the trademark dispute regarding "Doctor DOCTOR and Image" was resolved by the Beijing High People's Court, marking the end of a three-year legal dispute [5]
博士眼镜可转债获批 智能眼镜业务布局深化